150 related articles for article (PubMed ID: 23807438)
1. Synthesis and antiproliferative activity of the heterobimetallic complexes [RuClCp(PPh₃)-μ-dmoPTA-1κP:2κ²N,N'-MCl₂] (M = Co, Ni, Zn; dmoPTA = 3,7-dimethyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane).
Serrano-Ruiz M; Aguilera-Sáez LM; Lorenzo-Luis P; Padrón JM; Romerosa A
Dalton Trans; 2013 Aug; 42(31):11212-9. PubMed ID: 23807438
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of [RuClCp(HdmoPTA-κP)(PPh3)][CF3SO3] and the heterobimetallic complexes [RuClCp(PPh3)-μ-dmoPTA-1κP:2κ2N,N'-M(acac-κ2O,O')2] (M=Co, Ni, Zn; dmoPTA=3,7-dimethyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane).
Mena-Cruz A; Lorenzo-Luis P; Passarelli V; Romerosa A; Serrano-Ruiz M
Dalton Trans; 2011 Apr; 40(13):3237-44. PubMed ID: 21340064
[TBL] [Abstract][Full Text] [Related]
3. Water-soluble 3,7-dimethyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane (dmoPTA) as a polydentate ligand: synthesis of [RuClCp(PPh3)-mu-dmoPTA-1kappaP:2kappa2N,N'-Co(acac-kappa2O,O')2].H2O.
Mena-Cruz A; Lorenzo-Luis P; Romerosa A; Serrano-Ruiz M
Inorg Chem; 2008 Apr; 47(7):2246-8. PubMed ID: 18330982
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of the antiproliferative activity of [RuCp(PPh
Mendoza Z; Lorenzo-Luis P; Scalambra F; Padrón JM; Romerosa A
Dalton Trans; 2017 Jun; 46(25):8009-8012. PubMed ID: 28617514
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative activity of dmoPTA-Ru(II) complexes against human solid tumor cells.
Ríos-Luci C; León LG; Mena-Cruz A; Pérez-Roth E; Lorenzo-Luis P; Romerosa A; Padrón JM
Bioorg Med Chem Lett; 2011 Aug; 21(15):4568-71. PubMed ID: 21719285
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of the water soluble ligands dmPTA and dmoPTA and the complex [RuClCp(HdmoPTA)(PPh(3))](OSO(2)CF(3)) (dmPTA = N,N'-Dimethyl-1,3,5-triaza-7-phosphaadamantane, dmoPTA = 3,7-Dimethyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane, HdmoPTA = 3,7-H-3,7-Dimethyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane).
Mena-Cruz A; Lorenzo-Luis P; Romerosa A; Saoud M; Serrano-Ruiz M
Inorg Chem; 2007 Jul; 46(15):6120-8. PubMed ID: 17580932
[TBL] [Abstract][Full Text] [Related]
7. The Significant Influence of a Second Metal on the Antiproliferative Properties of the Complex [Ru(η
Kordestani N; Abas E; Grasa L; Alguacil A; Scalambra F; Romerosa A
Chemistry; 2022 Jan; 28(3):e202103048. PubMed ID: 34806242
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic copper(II), cobalt(II), zinc(II), and nickel(II) coordination compounds of clotrimazole.
Betanzos-Lara S; Gómez-Ruiz C; Barrón-Sosa LR; Gracia-Mora I; Flores-Álamo M; Barba-Behrens N
J Inorg Biochem; 2012 Sep; 114():82-93. PubMed ID: 22717722
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterisation and biological activities of [(p-cym)RuX(pz4lut)]n+ and [{(p-cym)RuX}2(μ-pz4lut)]n+ (X = Cl, H2O and pz4lut = α,α,α',α'-tetra(pyrazol-1-yl)-2,6-lutidine).
Tripathy SK; Surada RK; Manne RK; Mobin SM; Santra MK; Patra S
Dalton Trans; 2013 Oct; 42(39):14081-91. PubMed ID: 23938874
[TBL] [Abstract][Full Text] [Related]
10. Interaction of rac-[M(diimine)3]2+ (M=Co, Ni) complexes with CT DNA: role of 5,6-dmp ligand on DNA binding and cleavage and cytotoxicity.
Ramakrishnan S; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
Dalton Trans; 2011 Apr; 40(13):3245-56. PubMed ID: 21359327
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization and antitumor properties of two highly cytotoxic ruthenium(iii) complexes with bulky triazolopyrimidine ligands.
Łakomska I; Fandzloch M; Muzioł T; Lis T; Jezierska J
Dalton Trans; 2013 May; 42(17):6219-26. PubMed ID: 23328694
[TBL] [Abstract][Full Text] [Related]
12. 2,6-Bis(2,6-diethylphenyliminomethyl)pyridine coordination compounds with cobalt(II), nickel(II), copper(II), and zinc(II): synthesis, spectroscopic characterization, X-ray study and in vitro cytotoxicity.
Martinez-Bulit P; Garza-Ortíz A; Mijangos E; Barrón-Sosa L; Sánchez-Bartéz F; Gracia-Mora I; Flores-Parra A; Contreras R; Reedijk J; Barba-Behrens N
J Inorg Biochem; 2015 Jan; 142():1-7. PubMed ID: 25282405
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, molecular structure and evaluation of new organometallic ruthenium anticancer agents.
Camm KD; El-Sokkary A; Gott AL; Stockley PG; Belyaeva T; McGowan PC
Dalton Trans; 2009 Dec; (48):10914-25. PubMed ID: 20023922
[TBL] [Abstract][Full Text] [Related]
14. Ruthenium(II/III)-based compounds with encouraging antiproliferative activity against non-small-cell lung cancer.
Nagy EM; Pettenuzzo A; Boscutti G; Marchiò L; Dalla Via L; Fregona D
Chemistry; 2012 Nov; 18(45):14464-72. PubMed ID: 23012112
[TBL] [Abstract][Full Text] [Related]
15. Ruthenium(ii) and palladium(ii) homo- and heterobimetallic complexes: synthesis, crystal structures, theoretical calculations and biological studies.
Askari B; Amiri Rudbari H; Micale N; Schirmeister T; Efferth T; Seo EJ; Bruno G; Schwickert K
Dalton Trans; 2019 Nov; 48(42):15869-15887. PubMed ID: 31620752
[TBL] [Abstract][Full Text] [Related]
16. Insights into the κ-P,N Coordination of 1,3,5-Triaza-7-phosphaadamantane and Derivatives: κ-P,N-Heterometallic Complexes and a
Alguacil A; Scalambra F; Romerosa A
Inorg Chem; 2022 Apr; 61(15):5779-5791. PubMed ID: 35378037
[TBL] [Abstract][Full Text] [Related]
17. Cobalt(II), nickel(II) and copper(II) complexes of a hexadentate pyridine amide ligand. Effect of donor atom (ether vs. thioether) on coordination geometry, spin-state of cobalt and M(III)-M(II) redox potential.
Pandey S; Das PP; Singh AK; Mukherjee R
Dalton Trans; 2011 Oct; 40(40):10758-68. PubMed ID: 21952226
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterization, and anticancer activity of ruthenium-pyrazole complexes.
David S; Perkins RS; Fronczek FR; Kasiri S; Mandal SS; Srivastava RS
J Inorg Biochem; 2012 Jun; 111():33-9. PubMed ID: 22484498
[TBL] [Abstract][Full Text] [Related]
19. Anti-oxidant, in vitro, in vivo anti-inflammatory activity and antiproliferative activity of mefenamic acid and its metal complexes with manganese(II), cobalt(II), nickel(II), copper(II) and zinc(II).
Kovala-Demertzi D; Hadjipavlou-Litina D; Staninska M; Primikiri A; Kotoglou C; Demertzis MA
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):742-52. PubMed ID: 18720191
[TBL] [Abstract][Full Text] [Related]
20. Lipophilicity-dependent ruthenium N-heterocyclic carbene complexes as potential anticancer agents.
Lv G; Guo L; Qiu L; Yang H; Wang T; Liu H; Lin J
Dalton Trans; 2015 Apr; 44(16):7324-31. PubMed ID: 25797411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
